文献速递骨质疏松与代谢性骨病

胃肠道事件对骨质疏松症治疗持续性和依从性的影响:MUSIC-OS 研究 3、6、12 个月结果

The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study.
PubMed 文献 · Osteoporos Int · 2017-11-06

这项多国、前瞻性、观察性研究纳入 2943 例绝经后女性,评估胃肠道事件与骨质疏松症治疗自我报告依从性和持续性的关系。12 个月时 73.9% 患者仍在治疗,基线、3 个月和 6 个月发生胃肠道事件显著降低新使用者的 12 个月持续性,基线至 6 个月发生胃肠道事件者 12 个月 ADEOS 评分 ≥20 的比值显著更低。

要点

  • 12 个月时 73.9% 患者仍在骨质疏松症治疗中。
  • 基线、3 个月和 6 个月发生胃肠道事件显著降低新使用者 12 个月持续性。
  • 基线至 6 个月发生胃肠道事件者 12 个月 ADEOS 评分 ≥20 的比值显著更低。

核心结论

  • 胃肠道事件的发生与患者对骨质疏松症药物依从性和持续性较低的可能性相关。

研究设计与样本

  • MUSIC-OS 为多国、前瞻性、观察性研究,纳入 2943 例绝经后女性,其中 22.8% 为新使用者,其余为有经验使用者。
  • 胃肠道事件信息在入组时及随访第 3、6、12 个月收集,患者报告胃肠道事件和药物持续性并完成 12 条目 ADEOS 问卷。
  • 采用多变量 logistic 回归和一般线性模型分析各时间点胃肠道事件与 12 个月持续性和依从性的关联。

主要发现

  • 全部患者中 68.1% 在基线报告胃肠道事件;至第 12 个月,完成随访者中超过 80% 报告至少一次胃肠道问题。
  • 86.7% 患者在基线仅接受双膦酸盐治疗。
  • 第 12 个月时 73.9% 患者仍在治疗;logistic 回归显示,调整其他因素后,至第 6 个月有胃肠道问题者持续治疗的可能性显著更低。
  • 基线至第 6 个月发生胃肠道事件的患者,第 12 个月 ADEOS 评分 ≥20(被认为可预测依从性)的比值显著更低。

关键数值与推荐

  • ADEOS 评分 ≥20 被认为可预测依从性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: The goal of this multinational, prospective, observational study was to examine the relationship between gastrointestinal (GI) events and self-reported levels of medication adherence and persistence in postmenopausal women. A total of 73.9% of patients remained on their osteoporosis (OP) therapy at month 12, although the presence of a GI event at baseline, month 3, and month 6 significantly reduced month 12 persistence among new users. The odds of a month-12 ADEOS score ≥ 20 were significantly lower among patients who experienced a GI event between baseline and month 6. The occurrence of GI events was observed to be associated with a lower likelihood of patient adherence and persistence to OP medication. INTRODUCTION: This study examines the relationship between gastrointestinal (GI) events and self-reported adherence and persistence with initial osteoporosis (OP) therapy over the course of the first 12 months of treatment. METHODS: The Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study was a multinational, prospective, observational study examining the impact of GI events on OP management in postmenopausal women. Information regarding GI events was collected at the time of enrollment and at months 3, 6, and 12 of follow-up. Patients reported GI events and medication persistence and completed the 12-item Adherence Evaluation of Osteoporosis treatment (ADEOS) questionnaire. Multivariate logistic and general linear models examined the association between GI events at various time points and persistence and adherence at month 12. RESULTS: The study enrolled 2943 women; 22.8% were classified as new users of OP therapy and the remainder were considered experienced users. Across all patients, 68.1% reported GI events at baseline; by month 12, over 80% of subjects who completed follow-up reported at least one GI problem. The majority of patients (86.7%) were treated only with bisphosphonates at baseline. At month 12, 73.9% of patients remained on therapy; logistic regression revealed that those with GI problems by month 6 were significantly less likely to persist with treatment, after adjusting for other factors. The odds of a month 12 ADEOS score ≥ 20 (considered predictive of adherence) were significantly lower among patients who experienced a GI event between baseline and month 6. CONCLUSIONS: The occurrence of GI events was associated with a lower likelihood of patient adherence to and persistence with OP medication.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Modi A, Sen S, Adachi JD, et al. The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study. Osteoporos Int. 2017. PMID: 29110061. doi:10.1007/s00198-017-4271-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。